Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity

J Virol. 2023 Oct 31;97(10):e0082323. doi: 10.1128/jvi.00823-23. Epub 2023 Sep 28.

Abstract

Pathogenesis of HIV-1 is enhanced through several viral-encoded proteins that counteract a range of host restriction molecules. HIV-1 Nef counteracts the cell membrane protein SERINC5 by downregulating it from the cell surface, thereby enhancing virion infectivity. Some subtype B reference Envelope sequences have shown the ability to bypass SERINC5 infectivity restriction independent of Nef. However, it is not clear if and to what extent circulating HIV-1 strains can exhibit resistance to SERINC5 restriction. Using a panel of Envelope sequences isolated from 50 Tanzanians infected with non-B HIV-1 subtypes, we show that the lentiviral reporters pseudotyped with patient-derived Envelopes have reduced sensitivity to SERINC5 and that this sensitivity differed among viral subtypes. Moreover, we found that SERINC5 sensitivity within patient-derived Envelopes can be modulated by separate regions, highlighting the complexity of viral/host interactions.

Keywords: HIV-1; SERINC5; envelopes; non-B subtypes; patient-derived sequence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Membrane / metabolism
  • HIV Infections* / metabolism
  • HIV Infections* / virology
  • HIV-1* / classification
  • HIV-1* / pathogenicity
  • HIV-1* / physiology
  • Host Microbial Interactions*
  • Humans
  • Membrane Proteins* / metabolism
  • Tanzania
  • env Gene Products, Human Immunodeficiency Virus* / genetics
  • nef Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • env Gene Products, Human Immunodeficiency Virus
  • Membrane Proteins
  • nef Gene Products, Human Immunodeficiency Virus
  • SERINC5 protein, human